Cargando…
Twelve months fixed duration WHO multidrug therapy for multibacillary leprosy: incidence of relapses in Agra field based cohort study
BACKGROUND & OBJECTIVES: The reported low relapse rates after 24 months multidrug therapy (MDT) for multibacillary leprosy (MB) led to the recommendation of reducing duration of therapy to 12 months. However, only a few reports exist on long term follow up data after 12 months fixed duration the...
Autores principales: | Kumar, Anil, Girdhar, Anita, Girdhar, B.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868067/ https://www.ncbi.nlm.nih.gov/pubmed/24434261 |
Ejemplares similares
-
Six months fixed duration multidrug therapy in paucibacillary leprosy: risk of relapse and disability in Agra PB cohort study
por: Kumar, Anil, et al.
Publicado: (2012) -
Risk of developing disability in pre and post-multidrug therapy treatment among multibacillary leprosy: Agra MB Cohort study
por: Kumar, Anil, et al.
Publicado: (2012) -
WHO Multidrug Therapy for Leprosy: Epidemiology of Default in Treatment in Agra District, Uttar Pradesh, India
por: Kumar, Anil, et al.
Publicado: (2015) -
An Unsuspected Case of Relapsed Multibacillary Leprosy
por: Kim, Eun Jee, et al.
Publicado: (2014) -
Gene expression patterns associated with multidrug therapy in multibacillary leprosy
por: Ferreira, Helen, et al.
Publicado: (2022)